Yes, Found is a legitimate telehealth platform with licensed clinicians and real medical evaluation — legitimacy isn't the question worth spending time on. Whether its specific pricing and plan structure fit your situation is the more useful one.
If you want a simpler comparison point, Luma Health's flat semaglutide ($197/month) and tirzepatide ($297/month) skip the multi-tier plan structure entirely.
"Is Found legit" is a common search, and the short answer is yes — but legitimacy alone isn't a particularly useful filter in a market where most established platforms clear that bar. The more useful question is whether Found's specific structure fits what you need.
What Makes Found Legitimate
Found connects patients with board-certified clinicians trained in obesity medicine, following a real medical evaluation process (including lab work when clinically indicated) before prescribing. The platform offers both FDA-approved brand-name medications and compounded alternatives, sourced through licensed pharmacy partners. These are the basic markers of a legitimate telehealth weight-loss platform, and Found meets them.
What Legitimacy Doesn't Tell You
Being legitimate doesn't automatically mean a platform is the best fit for your specific situation. Found's plan structure — separate compounded, branded, and non-GLP-1 tiers with different billing models — means understanding your actual total cost requires more digging than a single advertised price. Patient reviews have also noted mixed experiences with cancellation and messaging-based communication, which is worth factoring in alongside its legitimate clinical foundation.
Rather than asking whether a platform is legitimate in the abstract, ask: is the specific plan I'm being offered priced transparently, does it match my insurance situation, and does the medication format and program structure fit what I actually want? Those questions matter more than a general legitimacy check once you've confirmed the basics (licensed clinicians, licensed pharmacy, real medical evaluation).
A Quick Legitimacy Checklist for Any Provider
Whether evaluating Found or any other platform: confirm clinicians are licensed in your state, confirm the pharmacy is properly licensed and willing to share that information, confirm you know your total monthly cost before committing, and confirm there's a real medical evaluation (not just a form that approves everyone) before a prescription is written.
Who Found Fits Best
- Want both compounded and brand-name options under one platform
- Value structured behavioral coaching and community features
- Are comfortable navigating multiple plan tiers to find your best fit
- Want one simple price without comparing plan tiers
- Don't need built-in coaching or community features
- Prefer predictable pricing regardless of dose
One plan.
One transparent price.
Compounded semaglutide at $197/month or tirzepatide at $297/month — medical evaluation, provider visits, and shipping all included.
Get Started → Or start your free health assessmentFrequently Asked Questions
No. Found works with board-certified clinicians and licensed pharmacy partners, and requires a real medical evaluation before prescribing — the basic markers of a legitimate telehealth platform.
Because Found segments its offering into multiple plan tiers (compounded, branded, non-GLP-1) with different billing structures, so understanding your true total cost takes more digging than a single advertised price.
It can, depending on your intake results — if risk factors like prediabetes or thyroid concerns come up, Found may order labs before approving treatment, typically billed separately from membership.
Confirm clinicians are licensed in your state, confirm the pharmacy's licensing directly, know your total monthly cost upfront, and confirm a real medical evaluation happens before any prescription.
Quality depends on the specific compounding pharmacy's licensing and standards, which is worth verifying independently regardless of which platform is prescribing.
It depends on your priorities. If you want coaching and community features, Found's structure may deliver real value. If you want the simplest possible price to compare, a single flat-rate plan is more straightforward.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PubMed 33567185
- U.S. Food and Drug Administration. Human Drug Compounding and the FD&C Act. FDA.gov. FDA.gov
- U.S. Food and Drug Administration. BeSafeRx: Your Source for Online Pharmacy Information. FDA.gov. 2026. FDA.gov